Essential role for Bim in mediating the apoptotic and antitumor activities of immunotoxins
- Author(s)
- Antignani, A; Segal, D; Simon, N; Kreitman, RJ; Huang, D; FitzGerald, DJ;
- Details
- Publication Year 2017,Volume 36,Issue #35,Page 4953-4962
- Journal Title
- Oncogene
- Publication Type
- Journal Article
- Abstract
- Protein synthesis is crucial for regulating cell homeostasis and, when unrestricted, it can lead to tumorigenesis. Immunotoxins derived from Pseudomonas exotoxin are antibody-toxin fusion proteins that inhibit protein synthesis of mammalian cells via ADP-ribosylation of the eukaryotic elongation factor-2. Here we investigate the role of the Bcl-2 family proteins in the response of cancer cells to immunotoxin challenge. Besides the well-known reduction of the prosurvival Bcl-2 family member, Mcl-1, following inhibition of protein synthesis, we show for the first time that immunotoxins also reduce the levels of selected proapoptotic BH-3-only proteins. Among these, only Bim protein levels correlated with the ability of immunotoxins to induce an apoptotic response. To support our findings, we verified that a Bim knockout completely abolished immunotoxin-mediated apoptosis. Further, mice bearing either wild-type or Bid knockout tumors responded to immunotoxin treatment with a decrease in growth kinetics, whereas mice engrafted with Bim knockout tumors showed no reduction in tumor size or prolongation of survival following immunotoxin treatment. From these results, we conclude that Bim expression is a major susceptibility factor for tumor cell death and, as such, constitutes a potential biomarker that could be evaluated before immunotoxin treatment. In support of this hypothesis, clinically, we analyzed patient cells before immunotoxin treatment and report that samples of hairy cell leukemia with high levels of Bim protein responded with a greater decrease in leukemic cell count compared with those samples expressing a low level of Bim.Oncogene advance online publication, 24 April 2017; doi:10.1038/onc.2017.111.
- Publisher
- Springer Nature
- Research Division(s)
- Cancer And Haematology
- PubMed ID
- 28436946
- Publisher's Version
- https://doi.org/10.1038/onc.2017.111
- NHMRC Grants
- NHMRC/1057742, NHMRC/1016701,
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2017-05-02 03:01:22
Last Modified: 2018-07-09 03:43:51